Study of PLA pre-treatment, enzymatic and model-compost degradation, and valorization of degradation products to bacterial nanocellulose

It is well acknowledged that microplastics are a major environmental problem and that the use of plastics, both petro- and bio- based, should be reduced. Nevertheless, it is also a necessity to reduce the amount of the already spread plastics. These cannot be easily degraded in the nature and accumulate in the food supply chain with major danger for animals and human life. It has been shown in the literature that advanced oxidation processes (AOPs) modify the surface of polylactic acid (PLA) materials in a way that bacteria more efficiently dock on their surface and eventually degrade them. In the present work we investigated the influence of different AOPs (ultrasounds, ultraviolet irradiation, and their combination) on the biodegradability of PLA films treated for different times between 1 and 6 h. The pre-treated samples have been degraded using a home model compost as well as a cocktail of commercial enzymes at mesophilic temperatures (37 °C and 42 °C, respectively). Degradation degree has been measured and degradation products have been identified. Excellent degradation of PLA films has been achieved with enzyme cocktail containing commercial alkaline proteases and lipases of up to 90% weight loss. For the first time, we also report valorization of PLA into bacterial nanocellulose after enzymatic hydrolysis of the samples

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Enhanced enzymatic depolymerization of polylactic acid (PLA) through plasma pretreatment and subsequent conversion to biopolymer

Polylactic acid (PLA) serves as a bio-based alternative to fossil-based single-use plastics, biodegrading at high temperatures (58°C) and humidity during industrial composting. Despite enzymes' ability to catalyze reactions at near-ambient temperatures, polymer rigidity can impede efficient depolymerization. To address these challenges, we conducted a study of enzymatic PLA degradation at 42°C combined with green plasma pretreatment to help disrupt the crystalline regions within the polymer. Here we report the effect of length of plasma pretreatment on the rate of PLA degradation by enzyme mix containing commercial enzymes with reported PLA degrading activity. Results indicate that a 5-minute plasma pretreatment significantly enhances enzymatic degradation, with a 16% weight loss achieved in 4 weeks—a two-fold increase compared to untreated PLA. Furthermore, we report the valorization of PLA into bacterial nanocellulose after enzymatic hydrolysis of the samples

Key Points of Advanced Oxidation Processes (AOPs) for Wastewater, Organic Pollutants and Pharmaceutical Waste Treatment: A Mini Review

Advanced oxidation procedures (AOPs) refer to a variety of technical procedures that produce OH radicals to sufficiently oxidize wastewater, organic pollutant streams, and toxic effluents from industrial, hospital, pharmaceutical and municipal wastes. Through the implementation of such procedures, the (post) treatment of such waste effluents leads to products that are more susceptible to bioremediation, are less toxic and possess less pollutant load. The basic mechanism produces free OH radicals and other reactive species such as superoxide anions, hydrogen peroxide, etc. A basic classification of AOPs is presented in this short review, analyzing the processes of UV/H2O2, Fenton and photo-Fenton, ozone-based (O3) processes, photocatalysis and sonolysis from chemical and equipment points of view to clarify the nature of the reactive species in each AOP and their advantages. Finally, combined AOP implementations are favored through the literature as an efficient solution in addressing the issue of global environmental waste management

Key Points of Advanced Oxidation Processes (AOPs) for Wastewater, Organic Pollutants and Pharmaceutical Waste Treatment: A Mini Review

Advanced oxidation procedures (AOPs) refer to a variety of technical procedures that produce OH radicals to sufficiently oxidize wastewater, organic pollutant streams, and toxic effluents from industrial, hospital, pharmaceutical and municipal wastes. Through the implementation of such procedures, the (post) treatment of such waste effluents leads to products that are more susceptible to bioremediation, are less toxic and possess less pollutant load. The basic mechanism produces free OH radicals and other reactive species such as superoxide anions, hydrogen peroxide, etc. A basic classification of AOPs is presented in this short review, analyzing the processes of UV/H2O2, Fenton and photo-Fenton, ozone-based (O3) processes, photocatalysis and sonolysis from chemical and equipment points of view to clarify the nature of the reactive species in each AOP and their advantages. Finally, combined AOP implementations are favored through the literature as an efficient solution in addressing the issue of global environmental waste management

Study on the influence of advanced treatment processes on the surface properties of polylactic acid for a bio-based circular economy for plastics

New biotechnological processes using microorganisms and/or enzymes to convert carbonaceous resources, either biomass or depolymerized plastics into a broad range of different bioproducts are recognized for their high potential for reduced energy consumption and reduced GHG emissions. However, the hydrophobicity, high molecular weight, chemical and structural composition of most of them hinders their biodegradation. A solution to reduce the impact of non-biodegradable polymers spread in the environment would be to make them biodegradable. Different approaches are evaluated for enhancing their biodegradation. The aim of this work is to develop and optimize the ultrasonication (US) and UV photodegradation and their combination as well as dielectric barrier discharge (DBD) plasma as pre‐treatment technologies, which change surface properties and enhance the biodegradation of plastic by surface oxidation and thus helping bacteria to dock on them. Polylactic acid (PLA) has been chosen as a model polymer to investigate its surface degradation by US, UV, and DBD plasma using surface characterization methods like X-ray Photoelectron Spectroscopy (XPS) and Confocal Laser Microscopy (CLSM), Atomic Force Microscopy (AFM) as well as FT-IR and drop contour analysis. Both US and UV affect the surface properties substantially by eliminating the oxygen content of the polymer but in a different way, while plasma oxidizes the surface

Classification of residential buildings in Cyprus based on their energy performance

The significance of the building sector in terms of energy consumption is well acknowledged. Scientific studies have shown that the potential of energy savings in the building sector is quite significant. In this view the knowledge of how the building stock of Cyprus behaves in terms of energy consumption is quite valuable. This knowledge will assist policy makers to formulate targeted measures aiming the improvement of energy efficiency and will provide valuable information for setting current legal standards and benchmarks in the energy performance certificate, a requirement of the 2002/91/EC Directive. Unfortunately, the existing knowledge on this subject is quite poor. As a remedy, and in order to improve our knowledge on the subject, a research project supported by the Research Promotion Foundation under the 2008 call is in operation since December 2008. This study will present the outline, the goals and the proposed methodology of the research project “Classification of buildings in Cyprus based on their energy performance” and will exhibit the initial findings of the survey questionnaire regarding the energy behavior and other characteristics of the residential building stock of Cyprus

4H-1,2,6-Thiadiazin-4-one-containing small molecule donors and additive effects on their performance in solution-processed organic solar cells

The optical, electrochemical, morphological and transport properties of a series of thiadiazinone (acceptor) and (thienyl)carbazoles (donor) containing π-extended donor-acceptor-donors (D-A-D) are presented. Systematic variations in the number of the thienyl units, the choice of branched or straight alkyl side chains and the use of a processing additive demonstrate their use as electron donors in bulk heterojunction solar cells blended with fullerene acceptors. The best power conversion efficiency (PCE) of 2.7% is achieved by adding to the D-A-D 3:fullerene blend a polydimethylsiloxane (PDMS) additive, that improves the morphology and doubles the hole mobility within the D-A-D:fullerene blend

4H-1,2,6-Thiadiazin-4-one-containing small molecule donors and additive effects on their performance in solution-processed organic solar cells

The optical, electrochemical, morphological and transport properties of a series of thiadiazinone (acceptor) and (thienyl)carbazoles (donor) containing π-extended donor–acceptor–donors (D–A–D) are presented. Systematic variations in the number of the thienyl units, the choice of branched or straight alkyl side chains and the use of a processing additive demonstrate their use as electron donors in bulk heterojunction solar cells blended with fullerene acceptors. The best power conversion efficiency (PCE) of 2.7% is achieved by adding to the D–A–D 3 : fullerene blend a polydimethylsiloxane (PDMS) additive, that improves the morphology and doubles the hole mobility within the D–A–D : fullerene blend